Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes

Go back to Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1112.21 +13.64 (1.24%)
Previous Close $1098.57    52 Week High $88.16 
Open $1112.24    52 Week Low $67.88 
Day High $1119.45    P/E 257.46 
Day Low $1093.15    EPS $4.32 
Volume 877,045